Particle.news

Download on the App Store

Lipid Nanoparticle Cargo, Not the Shell, Drives Dendritic Cell Fate, Belgian Study Finds

A preclinical Cell Reports study maps single-cell signatures that could guide safer vaccines or tolerogenic approaches.

Image

Overview

  • The VIB-UGent team with partners in Ghent and Brussels reports that dendritic cell outcomes depend on what lipid nanoparticles carry.
  • Using CITE-seq alongside flow cytometry, researchers identified distinct transcriptional and surface-protein signatures of immunogenic versus homeostatic maturation.
  • Empty lipid nanoparticles were weak activators of dendritic cells, indicating the lipid shell is not inherently decoded as dangerous.
  • mRNA-loaded or Toll-like receptor ligand–adjuvanted particles induced antiviral programs and T cell activation, consistent with immunogenic maturation.
  • Empty or peptide-loaded particles steered cells toward homeostatic states, a pattern the authors say could inform tolerogenic vaccine concepts pending further validation.